AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$662M
This Quarter Return
-9%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$646M
AUM Growth
+$646M
(-20%)
Cap. Flow
-$94.1M
Cap. Flow
% of AUM
-14.58%
Top 10 Holdings %
Top 10 Hldgs %
94.51%
Holding
15
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Dianthus Therapeutics
DNTH
|
$48.6M |
| 2 |
Disc Medicine
IRON
|
$33.7M |
| 3 |
Akero Therapeutics
AKRO
|
$11.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Disc Medicine
IRON
$2.07B
| $129M | 19.98% |
2,745,335
-716,449
| -21% | -$33.7M |
|
2
Day One Biopharmaceuticals
DAWN
$769M
| $93.4M | 14.46% |
7,608,394
| – | – |
|
3
Dyne Therapeutics
DYN
$1.92B
| $88.6M | 13.72% |
9,885,449
| – | – |
|
4
Kymera Therapeutics
KYMR
$2.95B
| $81.4M | 12.61% |
5,858,262
| – | – |
|
|
THRD
5
DELISTED
Third Harmonic Bio
THRD
| $69.7M | 10.8% |
10,907,859
| – | – |
|
6
Replimune Group
REPL
$422M
| $35.9M | 5.56% |
2,098,300
| – | – |
|
|
VIGL
7
DELISTED
Vigil Neuroscience
VIGL
| $31.5M | 4.87% |
5,836,874
| – | – |
|
8
Generation Bio
GBIO
$40.4M
| $31.4M | 4.86% |
8,279,484
| – | – |
|
|
JBIO
9
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $27.7M | 4.29% |
2,039,249
| – | – |
|
|
IMA
10
ImageneBio, Inc. Common Stock
IMA
$150M
| $21.7M | 3.37% |
5,018,178
| – | – |
|
|
11
Akero Therapeutics
AKRO
$3.74B
| $18.2M | 2.81% |
359,251
-235,000
| -40% | -$11.9M |
|
|
TECX
12
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $6.99M | 1.08% |
4,541,381
| – | – |
|
13
Xilio Therapeutics
XLO
$36.3M
| $5.82M | 0.9% |
2,759,344
| – | – |
|
|
14
Dianthus Therapeutics
DNTH
$759M
| $3.24M | 0.5% |
236,979
-3,554,719
| -94% | -$48.6M |
|
15
Spero Therapeutics
SPRO
$116M
| $1.23M | 0.19% |
1,013,438
| – | – |
|